EFG Asset Management Americas Corp. decreased its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 5.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,513 shares of the technology company’s stock after selling 785 shares during the period. EFG Asset Management Americas Corp.’s holdings in Veeva Systems were worth $3,891,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the stock. Trust Co. of Toledo NA OH acquired a new stake in shares of Veeva Systems during the second quarter valued at $29,000. Legacy Investment Solutions LLC acquired a new position in Veeva Systems in the 2nd quarter valued at about $32,000. Maseco LLP purchased a new position in Veeva Systems in the 2nd quarter valued at about $35,000. Ameritas Advisory Services LLC purchased a new position in Veeva Systems in the 2nd quarter valued at about $68,000. Finally, ORG Partners LLC boosted its stake in shares of Veeva Systems by 176.3% during the 2nd quarter. ORG Partners LLC now owns 315 shares of the technology company’s stock worth $89,000 after purchasing an additional 201 shares during the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Veeva Systems
In other news, SVP Jonathan Faddis sold 14,595 shares of the stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $300.00, for a total value of $4,378,500.00. Following the completion of the sale, the senior vice president owned 8,588 shares in the company, valued at approximately $2,576,400. This trade represents a 62.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the transaction, the insider directly owned 25,325 shares in the company, valued at $7,765,151.50. This trade represents a 19.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 24,665 shares of company stock valued at $7,438,000 over the last ninety days. Corporate insiders own 10.30% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Stock Report on Veeva Systems
Veeva Systems Trading Down 0.2%
VEEV stock opened at $273.21 on Thursday. The stock has a 50-day moving average price of $288.57 and a two-hundred day moving average price of $278.53. Veeva Systems Inc. has a 12-month low of $201.54 and a 12-month high of $310.50. The company has a market cap of $44.78 billion, a PE ratio of 56.10, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The firm had revenue of $789.08 million during the quarter, compared to analysts’ expectations of $768.49 million. During the same quarter last year, the business earned $1.62 earnings per share. The business’s revenue for the quarter was up 16.7% compared to the same quarter last year. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Equities analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- What is the FTSE 100 index?
- Applied Materials: Up 40% in 2025 With Room to Run Long-Term
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- onsemi Places a $6 Billion Bet on Its Own Stock
- 3 Warren Buffett Stocks to Buy Now
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
